The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...

Jonathan DiVincenzo, President & COO, reported that "revenue was consistent with our outlook and operating margin exceeded consensus, a testament to the discipline and agility of our teams in what ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a year earlier ...

Analytik Jena has introduced an optional module for 21 CFR Part 11 compliance. With this, the qpcrsoft 6.0 software now meets the requirements of the U.S. FDA regulation for electronic records and ...

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...

Sifting through countless of stocks in the Life Sciences Tools & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

Bio-Rad Laboratories has appointed Rajat Mehta as executive VP of global commercial operations, replacing Mike Crowley, who will be retiring. Mehta most recently served as senior VP overseeing ...